# Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

> **NCT05438212** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **NRG Oncology** · enrollment: 237 (actual)

## Conditions studied

- Metastatic Malignant Neoplasm in the Brain

## Interventions

- **PROCEDURE:** Brain Surgery
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **RADIATION:** Stereotactic Radiosurgery

## Key facts

- **NCT ID:** NCT05438212
- **Lead sponsor:** NRG Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-10-24
- **Primary completion:** 2027-03-16
- **Final completion:** 2027-03-16
- **Target enrollment:** 237 (ACTUAL)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05438212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05438212, "Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05438212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*